Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 221
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate
Review: Colorado Psychedelic Cup 2025
Dr Ros Watts – Building Communities and Connection
The Psychedelic News Feed: October 27 – November 02, 2025
Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months
Small Pharma Announces Engagement of Investor Relations Provider
Fear of Death Impacts Quality of Life-How Psychedelics Can Help
PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding...
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research...
COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment...
Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation...
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and...
The Therapeutic Effects of Psychedelics: 2A or Not 2A? – Part...
1
...
220
221
222
...
301
Page 221 of 301